OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development and Pharmacochemical Characterization Discover a Novel Brain-Permeable HDAC11-Selective Inhibitor with Therapeutic Potential by Regulating Neuroinflammation in Mice
Ping Bai, Yan Liu, Liuyue Yang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 16075-16090
Closed Access | Times Cited: 17

Showing 17 citing articles:

Comparative Structure-Based Virtual Screening Utilizing Optimized AlphaFold Model Identifies Selective HDAC11 Inhibitor
Fady Baselious, Sebastian Hilscher, Dina Robaa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1358-1358
Open Access | Times Cited: 10

Biological function and small molecule inhibitors of histone deacetylase 11
Geng Jia, Jinyu Liu, Xinlu Hou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116634-116634
Closed Access | Times Cited: 4

HDAC11 displays neuropathological alterations and offers as a novel drug target for Alzheimer's disease
Ping Bai, Prasenjit Mondal, Yan Liu, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access

Epigenetic mechanisms of bone cancer pain
Chaobo Ni, Liping Chen, Bohan Hua, et al.
Neuropharmacology (2024), pp. 110164-110164
Open Access | Times Cited: 3

Sulfur(VI) Fluoride Exchange Chemistry in Solid-Phase Synthesis of Compound Arrays: Discovery of Histone Deacetylase Inhibitors
Tobias Hansen, Daniela Danková, Michael Bæk, et al.
JACS Au (2024) Vol. 4, Iss. 5, pp. 1854-1862
Open Access | Times Cited: 2

Utilization of an optimized AlphaFold protein model for structure‐based design of a selective HDAC11 inhibitor with anti‐neuroblastoma activity
Fady Baselious, Sebastian Hilscher, Sven Hagemann, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Open Access | Times Cited: 2

Design, Synthesis, and Preclinical Evaluation of 11C/18F-Labeled Inhibitors for RIPK1 PET Imaging
Tian-Wen Luo, Yanting Zhou, Rui Wu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116851-116851
Closed Access | Times Cited: 1

PET Imaging Assist Investigation of HDAC6 Expression Change in MDD and Evaluating Antidepressant Efficacy of a Newly Developed HDAC6 Inhibitor
Xiao Zhong, Xiaoai Wu, Yanting Zhou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116908-116908
Closed Access | Times Cited: 1

Discovery of novel itaconimide-based derivatives as potent HDAC inhibitors for the efficient treatment of prostate cancer
Qihe Jiang, Yu-Jiang Tang, Qing-lan Hu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116315-116315
Closed Access | Times Cited: 1

The Effect of Pexidartinib on Neuropathic Pain via Influences on Microglia and Neuroinflammation in Mice
Liuyue Yang, Ashley Gomm, Ping Bai, et al.
Anesthesia & Analgesia (2024)
Closed Access

Distribution and diversity of classical deacylases in bacteria
Leonie G. Graf, Carlos Moreno–Yruela, Chuan Qin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access

Page 1

Scroll to top